The Use of Sacubitril/Valsartan for Hospitalized Heart Failure-Why Do We Care about Cost and Value?

Clyde W. Yancy; Adrian F. Hernandez; Robert O. Bonow

doi:10.1001/jamacardio.2020.3108

The Use of Sacubitril/Valsartan for Hospitalized Heart Failure-Why Do We Care about Cost and Value?

Clyde W. Yancy, Adrian F. Hernandez, Robert O. Bonow^*

^*Corresponding author for this work

Medicine, Cardiology Division

Research output: Contribution to journal › Comment/debate › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	1244
Number of pages	1
Journal	JAMA cardiology
Volume	5
Issue number	11
DOIs	https://doi.org/10.1001/jamacardio.2020.3108
State	Published - Nov 2020

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1001/jamacardio.2020.3108

Cite this

@article{776d61137c534d0aa7d0058ed688b90b,

title = "The Use of Sacubitril/Valsartan for Hospitalized Heart Failure-Why Do We Care about Cost and Value?",

author = "Yancy, {Clyde W.} and Hernandez, {Adrian F.} and Bonow, {Robert O.}",

year = "2020",

month = nov,

doi = "10.1001/jamacardio.2020.3108",

language = "English (US)",

volume = "5",

pages = "1244",

journal = "JAMA cardiology",

issn = "2380-6583",